文献速递神经肿瘤

库欣病患者静脉血栓栓塞及预防策略:系统综述

Venous Thromboembolism and Prevention Strategies in Patients with Cushing's Disease: A Systematic Review.
PubMed 文献 · World Neurosurg · 2024-09-07

本系统综述检索 Cochrane Library、EMBASE 和 Ovid MEDLINE,共纳入 25 篇文献,汇总库欣病经蝶手术后静脉血栓栓塞(VTE)发生率为 2%(58/2997),VTE 相关死亡率为 0.2%(6/2077)。良性促肾上腺皮质激素非依赖性库欣综合征患者肾上腺切除术后 191 例中无 VTE 发生,10 项研究报告了围手术期血栓预防策略。

要点

  • 库欣病经蝶手术后 VTE 汇总发生率为 2%(58/2997),VTE 相关死亡率为 0.2%(6/2077)。
  • 良性促肾上腺皮质激素非依赖性库欣综合征患者肾上腺切除术后 191 例中无 VTE 发生。
  • 库欣病术后 VTE 是致病原因之一,最佳药物预防策略尚需进一步研究。

核心结论

  • 库欣病术后 VTE 发生率为 2%、死亡率为 0.2%,提示手术切除促肾上腺皮质激素腺瘤未必立即逆转高凝状态。
  • 凝血因子生成增加、纤溶受损、炎症及库欣综合征相关代谢危险因素均参与高凝状态发病机制。
  • 最佳药物预防策略尚需进一步研究。

研究设计与样本

  • 系统综述,按照 PRISMA 指南检索 Cochrane Library、EMBASE 和 Ovid MEDLINE 数据库。
  • 共检出 944 篇文献,最终纳入 25 篇相关论文。

主要发现

  • 库欣病经蝶手术后 VTE 汇总发生率为 2%(58/2997)。
  • 基于报告该信息的 23 项研究,VTE 相关死亡率汇总为 0.2%(6/2077)。
  • 良性促肾上腺皮质激素非依赖性库欣综合征患者肾上腺切除术后 191 例中无 VTE 病例。
  • 10 项研究报告了经蝶手术和肾上腺切除术的围手术期血栓预防策略信息。

关键数值与推荐

  • 库欣病经蝶手术后 VTE 汇总发生率为 2%(58/2997)。
  • VTE 相关死亡率汇总为 0.2%(6/2077),基于 23 项报告该信息的研究。
  • 良性促肾上腺皮质激素非依赖性库欣综合征患者肾上腺切除术后 191 例中 VTE 发生率为 0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a well-documented association between Cushing's syndrome (CS) and hypercoagulability. However, there is limited data on the risk of venous thromboembolic events (VTEs) after surgery for Cushing's disease (CD). There is no consensus on optimal postoperative anticoagulation strategies in this group. This review gathers information on the rates of VTE after surgery for CD, as well as reported prophylaxis strategies in this population. METHODS: A literature search was performed using Cochrane Library, EMBASE, and Ovid MEDLINE databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A narrative review of papers discussing mechanisms of hypercoagulability in CS was conducted. RESULTS: Twenty-five relevant papers were identified out of 944 papers yielded. Pooled postoperative VTE incidence in patients undergoing transsphenoidal surgery for CD was 2% (58 out of 2997). The pooled rate of VTE-associated mortality based on the 23 studies that reported this information was 0.2% (6 out of 2077). There were no cases of postoperative VTE in the 191 patients undergoing adrenalectomy for benign adrenocorticotropic hormone-independent CS. Ten studies reported information on perioperative thromboprophylaxis strategies in transsphenoidal surgery for CD and adrenalectomy for adrenocorticotropic hormone-independent CS. CONCLUSIONS: Postoperative VTE in CD is a source of morbidity, with a rate of 2% and mortality rate of 0.2%, highlighting that surgical resection of the corticotroph adenoma does not necessarily result in immediate resolution of hypercoagulability. Increased production of coagulation factors, impaired fibrinolysis, inflammation, and CS-associated metabolic risk factors all factor into the pathogenesis of CS-associated hypercoagulability. Further study is needed on an optimal pharmacologic prophylaxis strategy.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. White AJ, Almeida JP, Filho LM, et al. Venous Thromboembolism and Prevention Strategies in Patients with Cushing's Disease: A Systematic Review. World Neurosurg. 2024. PMID: 39182834. doi:10.1016/j.wneu.2024.08.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。